Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
290.05
+43.00 (17.41%)
Aug 1, 2025, 4:00 PM - Market closed
Bio-Rad Laboratories Revenue
Bio-Rad Laboratories had revenue of $651.60M in the quarter ending June 30, 2025, with 2.06% growth. This brings the company's revenue in the last twelve months to $2.55B, down -0.32% year-over-year. In the year 2024, Bio-Rad Laboratories had annual revenue of $2.57B, down -3.92%.
Revenue (ttm)
$2.55B
Revenue Growth
-0.32%
P/S Ratio
2.94
Revenue / Employee
$318,085
Employees
8,030
Market Cap
7.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.57B | -104.70M | -3.92% |
Dec 31, 2023 | 2.67B | -131.00M | -4.67% |
Dec 31, 2022 | 2.80B | -120.35M | -4.12% |
Dec 31, 2021 | 2.92B | 376.92M | 14.81% |
Dec 31, 2020 | 2.55B | 233.97M | 10.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BIO.B News
- 22 hours ago - Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings - Benzinga
- 1 day ago - Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025 - Business Wire
- 1 day ago - Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Bio-Rad Reports Second-Quarter 2025 Financial Results - Business Wire
- 4 days ago - Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations - Business Wire
- 15 days ago - Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025 - Business Wire
- 26 days ago - Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout - Business Wire
- 2 months ago - Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference - Business Wire